总局公告,修订两药品说明书

2018-01-07 佚名 CFDA

1月5日,总局发布两则通告,要求修订“清热暗疮制剂、治伤风颗粒非处方药 ”的说明书,其中“清热暗疮制剂”分为处方药和非处方药

1月5日,总局发布两则通告,要求修订“清热暗疮制剂、治伤风颗粒非处方药
”的说明书,其中“清热暗疮制剂”分为处方药和非处方药,(详见文末附件)

两个产品都不是所谓的大产品,“清热暗疮制剂”在总局数据库中查询,有11个批准文号,知名的药企有广州王老吉。

另一个“治伤风颗粒”就更有意思,只有一个台湾明通化学制药股份有限公司第二厂的批准文号,算得上独家产品。

附:治伤风颗粒非处方药说明书修订要求

一、【规格】项修订为:

每袋装2克(相当于饮片1.236克,含对乙酰氨基酚240毫克,无水咖啡因50毫克,盐酸那可汀10毫克,马来酸氯苯那敏2毫克)。

二、【禁忌】项修订内容如下:

第1条修订为:“对马来酸氯苯那敏、对乙酰氨基酚、咖啡因、盐酸那可汀过敏者禁用。”

三、【注意事项】项修订内容如下:

第3条修订为:“本品含对乙酰氨基酚、无水咖啡因、盐酸那可汀、马来酸氯苯那敏。服用本品期间不得饮酒或含有酒精的饮料;不能同时服用与本品成份相似的其他抗感冒药;避免服用咖啡因药品、饮料;对阿司匹林过敏者慎用;肝、肾功能不全者慎用;膀胱颈梗阻、甲状腺功能亢进、青光眼、高血压、呼吸疾病(如慢性支气管炎、肺气肿、慢性肺疾病、呼吸急促、呼吸困难)和前列腺肥大者慎用;孕妇及哺乳期妇女慎用;新生儿、早产儿不宜使用;服药期间不得驾驶机、车、船、从事高空作业、机械作业及操作精密仪器。”

附:清热暗疮制剂处方药说明书修订要求

一、【不良反应】项应包括:

腹泻、腹痛、恶心、呕吐、胃不适、皮疹、瘙痒、头晕等。

二、【禁忌】项应包括:

1.孕妇禁用。
2.脾胃虚寒症见腹痛、喜暖、泄泻者禁用。
3.对本品及所含成份过敏者禁用。
三、【注意事项】项应包括:

1.保持面部卫生,切忌以手挤压患处。不宜滥用化妆品及外涂药物。
2.哺乳期妇女慎用。
3.严格按用法用量服用,本品不宜长期服用。
4.服药后出现胃脘不适,食欲减少,大便溏稀者应停服。
5.对本品过敏者禁用,过敏体质者慎用。

附:清热暗疮制剂非处方药说明书修订要求

一、【不良反应】项应包括:

腹泻、腹痛、恶心、呕吐、胃不适、皮疹、瘙痒、头晕等。

二、【禁忌】项应包括:

1.孕妇禁用。
2.脾胃虚寒症见腹痛、喜暖、泄泻者禁用。
3.对本品及所含成份过敏者禁用。

三、【注意事项】项应包括:

1.忌烟酒、辛辣、油腻及腥发食物。
2.保持面部卫生,切忌以手挤压患处。不宜滥用化妆品及外涂药物,必要时应在医师或药师指导下使用。
3.如有较多脓肿、囊肿、脓疱等损害者,应去医院就诊。
4.不宜在服药期间同时服用滋补性中药。
5.有高血压、心脏病、肝病、糖尿病、肾病等慢性病患者应在医师指导下服用。
6.哺乳期妇女慎用,且应由医师指导,儿童应在医师指导下服用。
7.服药后出现胃脘不适,食欲减少,大便溏稀者应停服。
8.服药7天症状无缓解,应去医院就诊。
9.严格按用法用量服用,本品不宜长期服用。
10.对本品过敏者禁用,过敏体质者慎用。
11.本品性状发生改变时禁止使用。
12.儿童必须在成人监护下使用。
13.请将本品放在儿童不能接触的地方。
14.如正在使用其他药品,使用本品前请咨询医师或药师。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=277404, encodeId=fe3f2e7404cf, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Jan 11 06:44:11 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507165, encodeId=b07d150e1659e, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Mon Jan 08 15:18:00 CST 2018, time=2018-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628844, encodeId=5a3b1628844a0, content=<a href='/topic/show?id=57c38e486a2' target=_blank style='color:#2F92EE;'>#药品说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87486, encryptionId=57c38e486a2, topicName=药品说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd8c21208991, createdName=fanweitanzhen, createdTime=Mon Jan 08 15:18:00 CST 2018, time=2018-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276245, encodeId=5d122e6245eb, content=^_^^_^^_^^_^^_^, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Sun Jan 07 07:16:38 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276228, encodeId=4ed12e6228fe, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Jan 07 07:09:06 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276218, encodeId=fd162e6218b6, content=厉害了我的哥, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Jan 07 06:49:45 CST 2018, time=2018-01-07, status=1, ipAttribution=)]
    2018-01-11 1209e435m98(暂无昵称)

    学习了.谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=277404, encodeId=fe3f2e7404cf, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Jan 11 06:44:11 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507165, encodeId=b07d150e1659e, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Mon Jan 08 15:18:00 CST 2018, time=2018-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628844, encodeId=5a3b1628844a0, content=<a href='/topic/show?id=57c38e486a2' target=_blank style='color:#2F92EE;'>#药品说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87486, encryptionId=57c38e486a2, topicName=药品说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd8c21208991, createdName=fanweitanzhen, createdTime=Mon Jan 08 15:18:00 CST 2018, time=2018-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276245, encodeId=5d122e6245eb, content=^_^^_^^_^^_^^_^, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Sun Jan 07 07:16:38 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276228, encodeId=4ed12e6228fe, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Jan 07 07:09:06 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276218, encodeId=fd162e6218b6, content=厉害了我的哥, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Jan 07 06:49:45 CST 2018, time=2018-01-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=277404, encodeId=fe3f2e7404cf, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Jan 11 06:44:11 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507165, encodeId=b07d150e1659e, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Mon Jan 08 15:18:00 CST 2018, time=2018-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628844, encodeId=5a3b1628844a0, content=<a href='/topic/show?id=57c38e486a2' target=_blank style='color:#2F92EE;'>#药品说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87486, encryptionId=57c38e486a2, topicName=药品说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd8c21208991, createdName=fanweitanzhen, createdTime=Mon Jan 08 15:18:00 CST 2018, time=2018-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276245, encodeId=5d122e6245eb, content=^_^^_^^_^^_^^_^, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Sun Jan 07 07:16:38 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276228, encodeId=4ed12e6228fe, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Jan 07 07:09:06 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276218, encodeId=fd162e6218b6, content=厉害了我的哥, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Jan 07 06:49:45 CST 2018, time=2018-01-07, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=277404, encodeId=fe3f2e7404cf, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Jan 11 06:44:11 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507165, encodeId=b07d150e1659e, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Mon Jan 08 15:18:00 CST 2018, time=2018-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628844, encodeId=5a3b1628844a0, content=<a href='/topic/show?id=57c38e486a2' target=_blank style='color:#2F92EE;'>#药品说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87486, encryptionId=57c38e486a2, topicName=药品说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd8c21208991, createdName=fanweitanzhen, createdTime=Mon Jan 08 15:18:00 CST 2018, time=2018-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276245, encodeId=5d122e6245eb, content=^_^^_^^_^^_^^_^, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Sun Jan 07 07:16:38 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276228, encodeId=4ed12e6228fe, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Jan 07 07:09:06 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276218, encodeId=fd162e6218b6, content=厉害了我的哥, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Jan 07 06:49:45 CST 2018, time=2018-01-07, status=1, ipAttribution=)]
    2018-01-07 wqkm

    ^_^^_^^_^^_^^_^

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=277404, encodeId=fe3f2e7404cf, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Jan 11 06:44:11 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507165, encodeId=b07d150e1659e, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Mon Jan 08 15:18:00 CST 2018, time=2018-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628844, encodeId=5a3b1628844a0, content=<a href='/topic/show?id=57c38e486a2' target=_blank style='color:#2F92EE;'>#药品说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87486, encryptionId=57c38e486a2, topicName=药品说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd8c21208991, createdName=fanweitanzhen, createdTime=Mon Jan 08 15:18:00 CST 2018, time=2018-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276245, encodeId=5d122e6245eb, content=^_^^_^^_^^_^^_^, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Sun Jan 07 07:16:38 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276228, encodeId=4ed12e6228fe, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Jan 07 07:09:06 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276218, encodeId=fd162e6218b6, content=厉害了我的哥, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Jan 07 06:49:45 CST 2018, time=2018-01-07, status=1, ipAttribution=)]
    2018-01-07 1209e435m98(暂无昵称)

    学习了.谢谢分享

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=277404, encodeId=fe3f2e7404cf, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Jan 11 06:44:11 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507165, encodeId=b07d150e1659e, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Mon Jan 08 15:18:00 CST 2018, time=2018-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628844, encodeId=5a3b1628844a0, content=<a href='/topic/show?id=57c38e486a2' target=_blank style='color:#2F92EE;'>#药品说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87486, encryptionId=57c38e486a2, topicName=药品说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd8c21208991, createdName=fanweitanzhen, createdTime=Mon Jan 08 15:18:00 CST 2018, time=2018-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276245, encodeId=5d122e6245eb, content=^_^^_^^_^^_^^_^, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Sun Jan 07 07:16:38 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276228, encodeId=4ed12e6228fe, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Jan 07 07:09:06 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276218, encodeId=fd162e6218b6, content=厉害了我的哥, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sun Jan 07 06:49:45 CST 2018, time=2018-01-07, status=1, ipAttribution=)]
    2018-01-07 飛歌

    厉害了我的哥

    0

相关资讯

52药品暂停销售!

52药品暂停销售!

CFDA发布首部《中国上市药品目录集》

首部《中国上市药品目录集》发布第一批收录131个药品203个品规

300药品不用两票制,都是畅销药

1月4日,河南科技大学第一附属医院发布《暂不执行两票制药品公示通知》,公示303个药品,暂不执行两票制。

CFDA重磅消息:第一批通过仿制药一致性评价品种公布!

根据《中华人民共和国药品管理法》、《国务院关于改革药品医疗器械审评审批制度的意见》(国发〔2015〕44号)、《国务院办公厅关于开展仿制药质量和疗效一致性评价的意见》(国办发〔2016〕8号)、《关于仿制药质量和疗效一致性评价工作有关事项的公告》(国家食品药品监督管理总局公告2017年第100号)的规定,经审查,现发布符合仿制药质量和疗效一致性评价要求的药品申请品种目录

重磅!首批通过一致性评价品种名单出炉,华海药业是很大赢家

12月29日,CFDA官网公布了第一批通过一致性评价的品种名单,首批通过一致性评价的共有17个品规药品,涉及11个药品,7个企业。其中,华海药业是最大赢家。

总局通报:20批药品不合格

元旦假期回来,不合格药品通报天天有,其中还不乏大企业、大品种,可见,新年伊始,药监严查力度再度升级。